Author:
Selinski Silvia,Blaszkewicz Meinolf,Ickstadt Katja,Hengstler Jan G.,Golka Klaus
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology,General Medicine
Reference59 articles.
1. Agúndez JA (2003) NAT2 genotyping: equilibrium between accuracy and feasibility in routine analyses. J Appl Res 3:1–6
2. Agúndez JA (2008) Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab 9:520–531
3. Agúndez JA, Golka K, Martínez C, Selinski S, Blaszkewicz M, García-Martín E (2008) Unraveling ambiguous NAT2 genotyping data. Clin Chem 54:1390–1394
4. An HR, Wu XQ, Wang ZY, Zhang JX, Liang Y (2012) NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients. Clin Exp Pharmacol Physiol 39:535–543
5. Arylamine N-Acetyltransferase Nomenclature Committee. Update July 22, 2011. http://www.louisville.edu/medschool/pharmacology/NAT.html . Accessed Feb 7, 2013
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献